![]() |
|
|
Vol. 54, Issue 5, 899-906, November 1998
-[35S]thiotriphosphate Binding to Liposomes
with Varying Muscarinic Receptor/Go Protein Stoichiometry
ek
Institute of Physiology, Academy of Sciences of the Czech Republic, 14220 Prague, Czechia (J.J., S.T.), and Department of Neurochemistry, Faculty of Medicine, University of Tokyo, Tokyo 113, Japan (T.H.)
| |
Summary |
|---|
|
|
|---|
We investigated whether alcuronium, an allosteric modulator of
muscarinic acetylcholine receptors, can induce receptor-mediated activation of Go proteins in liposomal membranes
incorporating purified M2 receptors and Go
proteins and whether its action is affected by the
receptor/Go protein (R/Go) ratio. The binding of guanosine-
-[35S]thiotriphosphate
([35S]GTP
S) served as the indicator of G protein
activation. It was stimulated by empty receptors at high receptor
densities, and the dose-response curve was shifted to the left by the
agonist carbachol and to the right by the antagonist atropine. At an
R/Go ratio of 300:100, the rate of
[35S]GTP
S binding was the same in the presence or
absence of 0.1 mM carbachol. Alcuronium increased the
binding of [35S]GTP
S at R/Go ratios of
<3:100 and diminished it at R/Go ratios of >10:100,
similar to previous observations on intact cells expressing muscarinic
receptors at different densities. The apparent biphasicity of
alcuronium action indicates that the allosteric modulator has at least
two effects on muscarinic receptor/G protein interaction but its
mechanistic basis is unclear. The "active state" of muscarinic receptors induced by alcuronium probably is different from that induced
by carbachol. Changes in the densities of receptors and Go
proteins had little effect on the kinetics of
[35S]GTP
S binding and on receptor affinity for
carbachol, provided the R/Go ratio was kept constant. This
suggests that the receptors and G proteins are located in microdomains
in which their concentrations remain constant, despite variations in
the amounts of lipidic membranes in the system.
| |
Introduction |
|---|
|
|
|---|
It
has been known for some time that the binding properties of muscarinic
acetylcholine receptors may be modulated by agents acting
allosterically (for a review, see Tu
ek and Pro
ka, 1995
) and that the allosteric modulators not only diminish (Clark and Mitchelson, 1976
; Stockton et al., 1983
), but also enhance
the affinity of the receptors for their orthosteric ligands
(Tu
ek et al., 1990
; Pro
ka and Tu
ek,
1994
; Guo et al., 1995
; Jakubík et al.,
1995b
, 1997
; Lazareno and Birdsall, 1995
). We found recently that
several allosteric modulators of muscarinic receptors (i.e., alcuronium, gallamine, and strychnine) not only modify the affinity of
the receptors for the agonists and antagonists but also influence the
interaction between the receptors and the G proteins (Jakubík et al., 1996
). In experiments on CHO cell lines stably
transfected with individual subtypes of muscarinic receptors,
allosteric modulators had agonist-like effects on the synthesis of cAMP
and of inositol phosphates in the cells. These effects could not be
blocked by the orthosteric muscarinic antagonist QNB and could not be
induced in cells that had not been transfected with the genes for
muscarinic receptors. In certain cases, the direction of the effect of
allosteric modulators on the synthesis of second messengers varied
depending on the density of muscarinic receptors in the cell line used.
In the current work, we investigated whether the interaction between
muscarinic receptors and a G protein also can be affected by the
allosteric modulator alcuronium in a simplified system consisting of
artificial lipid membranes incorporating purified M2 receptors and purified
Go proteins and whether it depends on the
stoichiometric ratio between the densities of the
M2 receptors and the Go
proteins (R/Go ratio). The effects of carbachol
(an orthosteric agonist) and atropine (an orthosteric antagonist) were
investigated in parallel with those of alcuronium. Receptor-mediated increases in the binding of [35S]GTP
S served
as the indicator of G protein activation. The results that we obtained
indicate that empty receptors can themselves activate the
Go proteins and that there are substantial
differences among the effects of the agonist, the allosteric modulator,
and the antagonist. The effects of the allosteric modulator vary
depending on the R/Go ratio. The "active
state" of muscarinic receptors induced by the allosteric modulator is
different from the "active state" induced by the orthosteric agonist.
| |
Experimental Procedures |
|---|
|
|
|---|
Materials.
Agarose (Sepharose 4-B) and DEAE-Sephadex were
from Pharmacia Fine Chemicals (Uppsala, Sweden), Ultrogel AcA-34 was
from Sepracor/IBF (Villeneuve la Garenne, France). Hydroxylapatite was
from Sigma Chemical (St. Louis, MO). DEAE-Toyopearl 650S was from Toyo
Soda MFG (Tokyo, Japan). Digitonin, phosphatidylcholine (from egg
yolk), and phosphatidylinositol
(L-
-phosphatidyl-D-myo-inositol-4-phosphate from bovine brain) were from Wako Pure Chemicals (Osaka, Japan). [3H]QNB (79 Ci/mmol) and
[35S]GTP
S (1 Ci/µmol) were from DuPont-NEN
(Boston, MA). ABT was synthesized (Haga and Haga, 1983
), and
ABT-agarose gel (Haga and Haga, 1985
) and heptylamine Sepharose
(Shaltiel, 1974
) were prepared as described.
Purification of muscarinic M2 receptors.
Receptors were obtained by solubilization of membranes of Sf9 cells
transiently expressing human m2 gene (Rinken et al., 1994
; Guo et al., 1995
). The membranes were treated with 1%
digitonin and 0.1% sodium cholate, and muscarinic receptors were
isolated by single-step affinity chromatography on ABT-agarose. After
elution with atropine, they were concentrated on hydroxylapatite
columns as described previously (Haga and Haga, 1985
). The purity of
the final preparation was checked by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis.
Isolation of G proteins.
Crude membranes were prepared from
porcine brains and their integral proteins were solubilized with 1%
sodium cholate. Go and Gi
proteins were isolated together by chromatography on DEAE-Sephacel, Ultrogel AcA 34, and heptylamine-Sepharose (Haga et al.,
1986
). DEAE-Toyopearl columns were used to separate the
Go from the Gi protein as
described previously (Haga et al., 1986
), except that 0.7%
3-[(3-cholamidopropyl)dimethylammonio]propanesulfonate was substituted for Lubrol PX in all solutions applied. The purity of
Go protein was confirmed by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis and Western blots (negative
reaction with monoclonal antibodies against Gi,
Gq, G11,
G16, and Gs, kindly provided by Dr. J. Novotný).
Reconstitution of M2 receptors and G proteins in
lipid vesicles.
The procedure was modified from that described by
Shiozaki and Haga (1992)
. The lipid mixture was obtained by mixing 4 volumes of a solution of cholesterol hemisuccinate (10 mg/ml in
methanol), 48 volumes of a solution of phosphatidyl choline (20 mg/ml
in chloroform), and 48 volumes of a solution of phosphatidyl inositol (20 mg/ml in chloroform). The solvents were evaporated with a stream of
nitrogen so as to obtain a thin layer of lipids on the wall of the test
tube. Then, the lipids were emulsified to form vesicles in a solution
of 20 mM K-HEPES, pH 8.0, 1 mM EDTA, 160 mM NaCl, and 1% sodium cholate by 30-min sonication at
4°. Vesicles were mixed with a suitable amount of purified
M2 receptors and separated on a column with 2 ml
of Sephadex G-50. A suitable amount of Go protein
was added to them, and the mixture was incubated on ice for 60 min,
after which it was diluted as requested.
S at its single
saturating concentration of 1 µM, again using
Whatman GF/B filters for the separation of vesicle-bound radioactivity.
These determinations were performed in the absence of GDP and in the
presence of Mg2+, ensuring virtually irreversible
[35S]GTP
S binding to all guanyl nucleotide
binding sites (Kd = 11-26 nM; Shiozaki and Haga, 1992
S binding) (i.e., the
R/Go ratio), was close to 1:100, 10:100, or
50:100. A fourth kind of vesicles also was used when required that
contained only muscarinic receptors but no G proteins (10:0), and the
fifth kind of vesicles contained only G proteins but no receptors
(0:100). An even broader scale of R/Go ratios was
applied in experiments described in Fig. 2.
Kinetics of [35S]GTP
S binding.
For
measurements of [35S]GTP
S binding to G
proteins in reconstituted vesicles, the vesicles were preincubated at
30° in 150 µl of a medium consisting of 10 mM
MgCl2, 1 mM dithiothreitol, and the
investigated muscarinic ligand. After 15 min (or 30 min, where
indicated), [35S]GTP
S and GDP were added to
final concentrations of 50 nM and 1 µM,
respectively, and the incubation was continued in a final volume of 200 µl as needed. The binding was arrested by the addition of 500 µl of
a stopping solution consisting of 50 mM Tris·HCl, pH 8.0, 100 mM NaCl, 5 mM MgCl2,
and 0.1 mM GTP, and the radioactivity bound to vesicles was
separated on Whatman GF/B filters. In experiments designed to compare
the effect of various concentrations of the same muscarinic ligand
on [35S]GTP
S binding (i.e., to obtain
concentration-response curves), [35S]GTP
S
association was arrested at a suitable time during the phase of linear
association, namely after 10 min in experiments with most ligands,
after 5 min in experiments with carbachol at the 50:100
R/Go ratio, or after 30 min in experiments with
atropine and alcuronium at the 1:100 and 10:100
R/Go ratios.
Treatment of data.
Data in figures and tables are mean ± standard error of three experiments performed with incubation in
duplicate. Values of Kd (equilibrium
dissociation constant for the binding of a ligand to a single
population of binding sites or to an undefined number of populations),
Klow, and Khigh
(equilibrium dissociation constants for the binding of a ligand to two
populations of binding sites displaying low and high affinity,
respectively), fhigh (fraction of binding sites
displaying high affinity and expressed as percentage of the total
number of the binding sites), Ki
(equilibrium dissociation constant of an inhibitor),
Bmax (maximum binding capacity),
EC50 (concentration of a ligand producing one
half of maximum effect), and kobs (apparent
association rate constant) were computed by nonlinear regression
according to accepted conventions (Limbird, 1986
; Hulme, 1992
;
Jakubík and Tu
ek, 1994a
, 1994b
; Jakubík et
al., 1995a
, 1995b
). Apparent association rate constants
(kobs) for the binding of
[35S]GTP
S to G proteins in liposomes were
obtained by fitting the equation
|
S in the presence
of muscarinic ligands were expressed as multiples of the
binding in their absence, and the concentration-response curves were
obtained by fitting the equation
|
S binding induced by a ligand
(Emax in Tables
1 and 2) corresponded to
Bmax/B0.
|
|
| |
Results |
|---|
|
|
|---|
Effects of carbachol, atropine, and alcuronium on
[35S]GTP
S association with reconstituted vesicles at
different R/Go.
The time course of the association of
[35S]GTP
S with G proteins in vesicles with
three different R/Go ratios is shown in Fig. 1. Characteristics of the vesicles used
and the numerical values computed from experiments in Fig. 1 are
summarized in Table 1. The effects of muscarinic ligands on the rates
of [35S]GTP
S association were investigated
in additional separate experiments on a broader scale of
R/Go ratios (Fig.
2).
|
|
S occurred not only to vesicles
reconstituted with receptors and Go proteins, but
also to vesicles that did not contain any receptors (0:100 ratio). In
the absence of receptors, carbachol, alcuronium, and atropine had no
effect on the rate of [35S]GTP
S binding. The
inclusion of receptors (with no accompanying ligand) into the membranes
enhanced the rate of [35S]GTP
S binding, with
kobs values changing from 0.026 min
1 at an R/Go ratio of
0:100 to 0.128 min
1 at an
R/Go ratio of 50:100 (Table 1). The rate of
[35S]GTP
S association was regularly
accelerated (compared with control samples) by carbachol. However, at
the highest R/Go ratio of 300:100, the rate of
[35S]GTP
S association in the absence of the
agonist reached the same high value as that which could be maximally
induced by carbachol (Fig. 2).
The rate of [35S]GTP
S association was not
affected by 100 nM atropine and, as long as atropine was
present, remained virtually the same at all R/Go
ratios between 0:100 and 50:100, although it became augmented at
R/Go ratios of 100:100 and 300:100. Because the
rate of [35S]GTP
S association was increased
by increases in the R/Go ratios in control
experiments (i.e., in the absence of any muscarinic ligand), it seemed
that atropine decelerated [35S]GTP
S
association at R/Go ratios of 30:100 and higher
(Figs. 1 and 2 and Table 1).
Compared with control samples, alcuronium enhanced the rate of
[35S]GTP
S association at
R/Go ratios of 0.3:100 and 1:100 (Figs. 1 and 2
and Table 1). Increasing R/Go ratios to higher
values had much less enhancing effect on the rates of
[35S]GTP
S association in the presence of
alcuronium than it had in the absence of muscarinic ligands. As a
result, the rate of [35S]GTP
S association
was faster in the presence of alcuronium than in control samples at low
R/Go ratios and slower than in control samples at
high R/Go ratios.
The concentration dependence of the effects of carbachol, alcuronium,
and atropine on the rates of [35S]GTP
S
binding to reconstituted vesicles with different
R/Go ratios is shown in Fig.
3 and relevant numerical data are
summarized in Table 1. The notable features of Fig. 3 include the
opposite effects of alcuronium at the 1:100 and 50:100
R/Go ratios and the higher relative inhibition of
[35S]GTP
S association rate by atropine at
the higher R/Go ratio.
|
Effects of carbachol, alcuronium, and atropine on
[35S]GTP
S association with reconstituted vesicles at
different densities of receptors and Go proteins.
Data
in the previous section were obtained in experiments in which the
concentration of the Go proteins in the
reconstituted vesicles was kept constant and the concentration of
receptors was varied. The observed variations in the binding rates were presented as a consequence of changes in the ratio of receptors to G
proteins. It might be argued that the rates of
[35S]GTP
S association were influenced by
changes in receptor densities in the membranes rather than by changes
in R/Go ratio. To check such an alternative
interpretation, experiments were performed in which the
R/Go ratio was kept at a constant level of 10:100 and the total amounts of receptors and Go
proteins per incubation tube also were kept constant, but the amounts
of the lipid mixture (and thus the numbers of vesicles and the areas of
the membranes available for receptor and G protein incorporation) used
for reconstitution were different. Three different sets of tubes were
used. In those with the "1 × Basic" densities, the densities
of receptors and Go proteins in liposomal
membranes were the same as they had been in the experiments described
in Figs. 1-3 and in Table 1 using the 10:100
R/Go ratio. In the tubes designated as
"0.1 × Basic" or "5 × Basic," the densities of
receptors and Go proteins were 10-fold lower or
5-fold higher, respectively, than for the "1 × Basic"
concentrations. The R/Go ratio always remained at
the 10:100 level.
S association were stable
both in the absence of muscarinic ligands and in the presence of 100 nM atropine or 10 µM alcuronium (Fig.
4 and Table 2). The
kobs values computed from experiments with
1 mM carbachol (Table 2) indicate that the rate of
[35S]GTP
S association was slightly but
significantly faster under the "5 × Basic" conditions (i.e.,
if the densities of receptors and G proteins were high).
Concentration-response curves shown in Fig.
5 confirm that the inhibitory effect of
atropine on [35S]GTP
S association was
virtually the same at the three concentrations of receptors and G
proteins examined and that various concentrations of alcuronium had
little effect under the conditions used in this set of experiments.
|
|
Inhibition of [3H]QNB binding to reconstituted vesicles by carbachol. It generally is assumed that receptors that are associated with a G protein display higher affinities for their agonists and that this can be seen in agonist-versus-antagonist competition binding curves. To obtain information about this aspect of our system, we performed competition binding experiments (carbachol versus [3H]QNB) on vesicles in which the R/Go ratios were 1:100, 10:100, 50:100, or 10:0. As shown in Fig. 6 (left), the curves describing the inhibition of [3H]QNB binding by carbachol differed in their steepness and their left-to-right position depending on the R/Go ratio. The higher the relative density of receptors (compared with that of G proteins), the more to the right and the steeper were the binding curves, suggesting that the proportion of receptors coupled to Go ([RG]/[Rtotal]) was the highest in the vesicles with the 1:100 R/Go ratio and the lowest in the vesicles without G proteins. The fraction of the high affinity binding sites (presumably reflecting the proportion of receptor/G protein complexes) computed from the binding data diminished from 73% at the 1:100 R/Go ratio to 16% at the 50:100 R/Go ratio.
|
| |
Discussion |
|---|
|
|
|---|
Artificial membranes reconstituted with purified G protein-coupled
receptors and G proteins have been fruitfully used for investigations
of receptor/G protein interactions (for a review, see Birnbaumer and
Birnbaumer, 1995
). Although many aspects of these interactions remain
controversial (Chidiac and Wells, 1992
), two points have been generally
accepted:
First, agonist-liganded receptors diminish the affinity of G proteins
for GDP and stimulate the dissociation of GDP from them (Brandt and
Ross, 1986
; Tota et al., 1987
; Florio and Sternweis, 1989
;
Haga et al., 1989
; Shiozaki and Haga, 1992
).
Second, agonist-liganded receptors stimulate the binding of GTP or its
unhydrolyzable analogue [35S]GTP
S to G
proteins, and this is mainly due to the receptor-induced decrease in
the binding of GDP. In studies of reconstituted systems containing
Gi and Go, the addition of
GDP was necessary to reveal the effect of agonists on
[35S]GTP
S binding (Florio and Sternweis,
1989
; Ikegaya et al., 1990
; Shiozaki and Haga, 1992
; but see
Kurose et al., 1986
, and Freissmuth et al.,
1991a
), whereas the addition of GDP was not necessary in systems
containing Gs (Cerione et al., 1985
;
Brandt and Ross, 1986
; Freissmuth et al., 1991b
) or
Gq (Nakamura et al., 1995
). The
meaning of these differences is not clear, and their analysis is
difficult in view of the tight binding of GDP to G proteins (Ferguson
et al., 1986
).
Our data offer several new insights with regard to Go protein activation by unliganded muscarinic receptors and by receptors associated with an agonist, antagonist, or allosteric modulator, to the importance of the R/Go ratio, and to the likely spacial organization of receptors and G proteins in liposomal membranes. The following are the most important findings.
Empty muscarinic receptors increase the apparent rate of
[35S]GTP
S binding to Go proteins.
When present at a high concentration (R/Go
ratio = 300:100), empty receptors were able to activate the
Go proteins to the same degree as the
agonist-liganded receptors (Fig. 2). Similar effects of empty
A1 adenosine and
-adrenergic receptors have been noted (Schütz and Freissmuth, 1992
).
Atropine prevents or diminishes the agonist-independent stimulatory
effects of muscarinic receptors on [35S]GTP
S
binding.
However, increases in the rate of
[35S]GTP
S binding could be observed even in
the presence of atropine if the R/Go ratio was raised above 50:100 (Fig. 2). It seems that the effect of atropine can
be viewed as an increase of the EC50
concentration of receptors required for Go activation.
Carbachol increases the apparent rate of
[35S]GTP
S binding to Go proteins and its
effect varies with the R/Go ratio.
Although the
enhancement of [35S]GTP
S binding by
muscarinic agonist was expected (Kurose et al., 1986
; Florio
and Sternweis, 1989
; Hilf et al., 1989
; Shiozaki and Haga,
1992
; Lazareno and Birdsall, 1993
; Nakamura et al., 1995
),
several features of the current data merit attention:
S binding approaches a maximum when
the R:Go ratio reaches 1:100 and is changed
little by further increases in the relative density of receptors (Figs.
1 and 2, Table 1). Although the ceiling in the amount of
[35S]GTP
S bound is given by the quantity of
Go available for binding, it is not clear what
determines the ceiling in the rate of
[35S]GTP
S binding at increasing receptor concentrations.
Second, carbachol brings about a leftward shift of the curve describing
how the rate of [35S]GTP
S association
depends on the concentration of receptors, and its effect can be viewed
as a decrease in the EC50 concentration of
receptors required for Go activation.
Third, the concentration of carbachol necessary for its half-maximal
effect on [35S]GTP
S binding
(EC50 of carbachol) increases with increasing R/Go ratios (Table 1). This can be explained by
changes in the proportion of receptors that are physically associated
with G proteins (Fig. 6 and Table 3).
Although the absolute number of RG complexes increases with increasing
R/Go ratios, the proportion of coupled receptors
(RG as a percentage of Rtotal) decreases, and
this is the likely cause of the increases in the
EC50 values. A very small increase of the
EC50 values for carbachol also was observed when
the R/Go ratios were kept constant, but the
densities of receptors and G proteins were augmented (Table 2). In this case, the above explanation cannot be applied, and we are uncertain as
to the likely reason.
|
Alcuronium affects the binding of [35S]GTP
S to
Go proteins in two directions.
Compared with the
binding that occurs in the absence of alcuronium, the binding of
[35S]GTP
S in the presence of alcuronium is
enhanced at low R/Go ratios (<10:100) and
diminished at high R/Go ratios (>10:100; Figs.
1-3). This point is discussed further.
The effects of carbachol, atropine, and alcuronium on
[35S]GTP
S binding are all receptor mediated.
The
three ligands had no effect when receptors were absent from the system
(Table 1).
The kinetics of [35S]GTP
S association with the
vesicles are affected very little by changes in the density of
receptors and Go proteins as long as the R/Go
ratio remains constant.
The most likely explanation of relevant
observations (Fig. 4 and Table 2) is that muscarinic receptors and
Go proteins are not uniformly dispersed in
liposomal membranes but rather are clustered in microdomains in which
their concentrations remain nearly constant despite variations in the
amounts of lipidic membranes in the system. The agglomeration of
signaling proteins in microdomains of cell surface membranes has been
highlighted by Neubig (1994
; see also Huang et al., 1997
).
Increases in R/Go ratios bring about decreases of the fraction of receptors displaying high affinity for the agonist carbachol. The higher the R/Go ratio, the lower proportion of receptor molecules could be expected to be associated with a G protein. Data in Fig. 6 (left) and Table 3 thus support the notion that receptors associated with G proteins (RG complexes) have a higher affinity for the agonist than free receptors. When, however, the densities of receptors and G proteins in liposomal membranes were manipulated by altering the amount of lipid membranes (Fig. 6, right; Table 3), no change occurred in the fraction of receptors with a high affinity for the agonist. As pointed out, such behavior of the system can be explained on the assumption that the receptors and G proteins are clustered within microdomains in which their densities remain constant.
Judging from its effects on [35S]GTP
S
binding, the allosteric modulator alcuronium can either increase or
diminish the activating influence of muscarinic
M2 receptors on Go
proteins, depending on the R/Go ratio. This
corresponds to what had been observed on intact CHO cells expressing
the M1 muscarinic receptors. In cells with a low
density of receptors, alcuronium enhanced the production of inositol
phosphates, whereas in cells with a high density of receptors (and
presumably a high R/G ratio), the production of inositol phosphates was
diminished by alcuronium (Jakubík et al., 1996
S binding
by G proteins, which occur simultaneously but are differently
pronounced at different R/Go ratios: one
supporting [35S]GTP
S binding to G proteins,
which prevails at low R/Go ratios, and another
inhibiting [35S]GTP
S binding, which prevails
at high R/Go ratios. Among the functional
parameters that might be affected by alcuronium binding to receptors in
opposite ways are (1) the rates of receptor/G protein association and
dissociation and the resulting affinity of the receptor for the G
protein, (2) the velocity of receptor-catalyzed guanine nucleotide
exchange, (3) the size and direction of receptor-induced changes in the
rates of GDP and, independently, GTP association to and dissociation
from the G protein and of the resulting affinities for GDP and for GTP,
and others. At least some of the conceivable effects of
alcuronium are likely to carry different weight depending on whether
the receptor (acting as the catalyst) is saturated with the G protein
as its substrate (at a low R/G ratio) or undersaturated (at a high R/G
ratio). This consideration applies to situations in which receptors and
G proteins interact as independent monomers and bind in a 1:1 ratio.
Alternative interpretations can be based on the assumption of an
oligomeric arrangement of receptors and G proteins (Chidiac and Wells,
1992| |
Acknowledgments |
|---|
We thank Hoffmann-La Roche (Basel, Switzerland) for providing alcuronium and Prof. E. E. El-Fakahany (Minneapolis, MN) for collaboration and extensive help.
| |
Footnotes |
|---|
Received January 30, 1998; Accepted July 7, 1998
1 Current affiliation: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 20892.
This work was supported by Grant 309/96/1287 from the Grant Agency of the Czech Republic (S.T.), National Institutes of Health Fogarty International Research Collaboration Award 2-R03-TW00171 (E.E.El-Fakahany), and a Travel Grant of the Japan Society for the Promotion of Science (J.J.).
Send reprint requests to: Dr. S. Tu
ek, Institute of
Physiology AV CR, Víde
ská 1083, 14220 Prague,
Czech Republic. E-mail: tucek{at}biomed.cas.cz
| |
Abbreviations |
|---|
ABT, 3-[2'-aminobenzhydryl-oxy]tropane;
CHO, Chinese hamster ovary;
GTP
S, guanosine-
-thiotriphosphate;
HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid;
QNB, quinuclidinyl benzilate;
R/Go ratio, ratio between the
densities of muscarinic receptors and Go proteins.
| |
References |
|---|
|
|
|---|
-adrenergic receptor and rhodopsin with guanine nucleotide regulatory proteins reconstituted in phospholipid vesicles.
J Biol Chem
260:
1493-1500
-adrenergic receptors in Escherichia coli: functional interaction with two forms of the stimulatory G protein.
Proc Natl Acad Sci USA
88:
8548-8552
ek S
(1994a)
Protection by alcuronium of muscarinic receptors against chemical inactivation and location of the allosteric binding site for alcuronium.
J Neurochem
63:
1932-1940[Medline].
ek S
(1994b)
Two populations of muscarinic binding sites in the chick heart distinguished by affinities for ligands and selective inactivation.
Br J Pharmacol
113:
1529-1537[Medline].
áková L,
El-Fakahany EE and
Tu
ek S
(1995a)
Constitutive activity of the M1
M4 subtypes of muscarinic receptors in transfected CHO cells and of muscarinic receptors in the heart cells revealed by negative antagonists.
FEBS Lett
377:
275-279[Medline].
áková L,
El-Fakahany EE and
Tu
ek S
(1995b)
Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
J Pharmacol Exp Ther
274:
1077-1083
áková L,
Lisá V,
El-Fakahany EE and
Tu
ek S
(1996)
Activation of muscarinic acetylcholine receptors via their allosteric binding sites.
Proc Natl Acad Sci USA
93:
8705-8709
áková L,
El-Fakahany EE and
Tu
ek S
(1997)
Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.
Mol Pharmacol
52:
172-179
S binding mediated by human muscarinic m1-m4 receptors: antagonist studies.
Br J Pharmacol
109:
1120-1127[Medline].
(G14
), GL2
(G11
), and Gq
expressed in the baculovirus-insect cell system.
J Biol Chem
270:
6246-6253
ka J and
Tu
ek S
(1994)
Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors.
Mol Pharmacol
45:
709-717[Abstract].
ek S,
Musílková J,
Nedoma J,
Pro
ka J,
Shelkovnikov S and
Vorlí
ek J
(1990)
Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
Mol Pharmacol
38:
674-680[Abstract].
ek S and
Pro
ka J
(1995)
Allosteric modulation of muscarinic acetylcholine receptors.
Trends Pharmacol Sci
16:
205-212[Medline].This article has been cited by other articles:
![]() |
E. Machova, J. Jakubik, E. E. El-Fakahany, and V. Dolezal Wash-Resistantly Bound Xanomeline Inhibits Acetylcholine Release by Persistent Activation of Presynaptic M2 and M4 Muscarinic Receptors in Rat Brain J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 316 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Michal, E. E. El-Fakahany, and V. Dolezal Muscarinic M2 Receptors Directly Activate Gq/11 and Gs G-Proteins J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 607 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Langmead, V. A. H. Fry, I. T. Forbes, C. L. Branch, A. Christopoulos, M. D. Wood, and H. J. Herdon Probing the Molecular Mechanism of Interaction between 4-n-Butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the Muscarinic M1 Receptor: Direct Pharmacological Evidence That AC-42 Is an Allosteric Agonist Mol. Pharmacol., January 1, 2006; 69(1): 236 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. T. May, Y. Lin, P. M. Sexton, and A. Christopoulos Regulation of M2 Muscarinic Acetylcholine Receptor Expression and Signaling by Prolonged Exposure to Allosteric Modulators J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 382 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jakubik, S. Tucek, and E. E. El-Fakahany Role of Receptor Protein and Membrane Lipids in Xanomeline Wash-Resistant Binding to Muscarinic M1 Receptors J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 105 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cordeaux, S. A. Nickolls, L. A. Flood, S. G. Graber, and P. G. Strange Agonist Regulation of D2 Dopamine Receptor/G Protein Interaction. EVIDENCE FOR AGONIST SELECTION OF G PROTEIN SUBTYPE J. Biol. Chem., July 27, 2001; 276(31): 28667 - 28675. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||